ArticleCureus2025

Dual Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonist-Associated Thyroiditis: A Case Report of Thyroid Dysfunction Following Tirzepatide Use.

Sara Humaida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.